KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Amortization of Deferred Charges (2016 - 2025)

National Health Investors (NHI) has disclosed Amortization of Deferred Charges for 16 consecutive years, with -$1.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortization of Deferred Charges fell 92.96% year-over-year to -$1.4 million, compared with a TTM value of $3.4 million through Dec 2025, down 9.41%, and an annual FY2025 reading of $3.4 million, down 9.41% over the prior year.
  • Amortization of Deferred Charges was -$1.4 million for Q4 2025 at National Health Investors, down from $4.5 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $4.5 million in Q3 2025 and bottomed at -$1.4 million in Q4 2025.
  • Average Amortization of Deferred Charges over 5 years is $754150.0, with a median of $139500.0 recorded in 2021.
  • Peak annual rise in Amortization of Deferred Charges hit 1979.37% in 2023, while the deepest fall reached 1164.29% in 2023.
  • Year by year, Amortization of Deferred Charges stood at $3.7 million in 2021, then tumbled by 98.11% to $70000.0 in 2022, then plummeted by 1164.29% to -$745000.0 in 2023, then increased by 0.81% to -$739000.0 in 2024, then plummeted by 92.96% to -$1.4 million in 2025.
  • Business Quant data shows Amortization of Deferred Charges for NHI at -$1.4 million in Q4 2025, $4.5 million in Q3 2025, and $213000.0 in Q2 2025.